These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18642455)

  • 1. Effect of amino acid mismatch in the UNOS 2007 dataset.
    Sasaki N; Idica A; Hall B; Terasaki P
    Clin Transpl; 2007; ():241-54. PubMed ID: 18642455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of amino acid mismatch in the UNOS dataset.
    Sasaki N; El-Awar N; Idica A
    Clin Transpl; 2011; ():299-309. PubMed ID: 22755423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA matching by amino acid/positions in double and triple combinations.
    Idica A; Sasaki N; Terasaki P
    Clin Transpl; 2006; ():123-38. PubMed ID: 18365374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HLA-matching effect in different cohorts of kidney transplant recipients: 10 years later.
    Sasaki N; Idica A
    Clin Transpl; 2010; ():261-82. PubMed ID: 21696046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA Matching in Pediatric Kidney Transplantation: HLA Poorly Matched Living Donor Transplants Versus HLA Well-Matched Deceased Donor Transplants.
    Opelz G; Döhler B; Middleton D; Süsal C;
    Transplantation; 2017 Nov; 101(11):2789-2792. PubMed ID: 28471872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate analysis of the effectiveness of using antibody induction therapy according to the degree of HLA mismatches.
    Bunnapradist S; Hong A; Lee B; Takemoto SK
    Transplant Proc; 2005 Mar; 37(2):886-8. PubMed ID: 15848565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the mimetic epitope concept to find a possible way to widen the graft-survival difference between matched and mismatched renal transplants.
    Sasaki N; Idica A; Hall B; Terasaki PI
    Clin Transpl; 2008; ():241-52. PubMed ID: 19711515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refinement of permissible HLA mismatches.
    Takemoto S; Terasaki PI
    Clin Transpl; 1994; ():451-66. PubMed ID: 7547575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept.
    Doxiadis II; Smits JM; Schreuder GM; Persijn GG; van Houwelingen HC; van Rood JJ; Claas FH
    Lancet; 1996 Sep; 348(9031):850-3. PubMed ID: 8826810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1996; ():1-14. PubMed ID: 9286555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of HLA compatibility in recipients of kidneys from expanded criteria donors: A Collaborative Transplant Study Report.
    Echterdiek F; Latus J; Döhler B; Schwenger V; Süsal C
    Int J Immunogenet; 2021 Apr; 48(2):201-210. PubMed ID: 32945128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA matching: identification of permissible HLA mismatches.
    Maruya E; Takemoto S; Terasaki PI
    Clin Transpl; 1993; ():511-20. PubMed ID: 7918185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of histocompatibility on graft rejection and graft survival within a single center population of heart transplant recipients.
    Sheldon S; Yonan NA; Aziz TN; Hasleton PS; Rahman AN; Deiraniya AK; Campbell CS; Dyer PA
    Transplantation; 1999 Aug; 68(4):515-9. PubMed ID: 10480409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney transplantation in the US: an analysis of the OPTN/UNOS registry.
    Freitas MC
    Clin Transpl; 2011; ():1-16. PubMed ID: 22755397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview and epitope matching.
    Terasaki PI; Park MS; Takemoto S; Cecka JM; Clark B; Corcoran S; Cicciarelli J; Barbetti A; Yuge J; Carnahan E
    Clin Transpl; 1989; ():499-516. PubMed ID: 2484860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
    Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of HLA matching on renal transplant survival.
    Zhou YC; Cecka JM
    Clin Transpl; 1993; ():499-510. PubMed ID: 7918184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.